NFKB1 and COVID-19: Importantly, as summarized in a recent review, NF-κB activation was proposed to have a central role in the COVID-19-induced cytokine/chemokine storm [42], and the treatment of COVID-19 patients with artesimin based on its NF-κB and cytokine production inhibiting activity was proposed in a recent paper by Tang et al. [148].